Exact Mass: 431.0303028
Exact Mass Matches: 431.0303028
Found 61 metabolites which its exact mass value is equals to given mass value 431.0303028
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rimsulfuron
CONFIDENCE standard compound; EAWAG_UCHEM_ID 130 EAWAG_UCHEM_ID 130; CONFIDENCE standard compound
4-Ketoanhydrochlortetracycline
C20H14ClNO8 (431.04079140000005)
Benzthiazide
C15H14ClN3O4S3 (430.98349540000004)
Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue. C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
Pimasertib
C15H15FIN3O3 (431.01421619999996)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Pimasertib (AS703026) is a highly selective, ATP non-competitive allosteric orally available MEK1/2 inhibitor[1][2].
[[(2r,3s,4r,5r)-5-(4-Azanyl-2-Oxidanylidene-Pyrimidin-1-Yl)-3,4-Bis(Oxidanyl)oxolan-2-Yl]methoxy-Oxidanyl-Phosphoryl]oxy-(2-Hydroxyethyl)phosphinic Acid
C11H19N3O11P2 (431.04948039999994)
2-Fluorobutyl 2-(8-azabicyclo[3.2.1]octan-1-yl)-5-iodobenzoate
C18H23FINO2 (431.07574999999997)
N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide
C17H10Cl2F3N3O3 (431.00512860000003)
Ioflupane
C18H23FINO2 (431.07574999999997)
Ferric Maltol
C18H15FeO9 (431.00654299999997)
8-Acetamido-1,1,1,15,15-pentachloropentadeca-3,12-diyne
4-Dedimethylamine-4-oxo-anhydro-7-Cl-tetracycline
C20H14ClNO8 (431.04079140000005)
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
C19H18IN3O (431.04945680000003)
cyclopenta-1,3-diene,9H-fluoren-9-ide,propan-2-ylidenezirconium(2+),dichloride
8-((6-BROMOBENZO[D][1,3]DIOXOL-5-YL)THIO)-9-(PENT-4-YN-1-YL)-9H-PURIN-6-AMINE
C17H14BrN5O2S (431.00515240000004)
Thiazolidine, 2-(2-chlorophenyl)-3-[(4-phenoxyphenyl)sulfonyl]- (9CI)
BTZ043
C17H16F3N3O5S (431.07627220000006)
TRANS-4-[2-(1-FERROCENYL)VINYL]-1-METHYLPYRIDINIUM IODIDE
2-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]benzoic acid, sodium salt
N-(2-CARBOXY-4,5-DICHLOROBENZOYL)-(-)-10,2-CAMPHORSULTAM
C18H19Cl2NO5S (431.0360944000001)
N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-(PYRIDIN-3-YLOXY)PHENYL)-1H-1,2,4-TRIAZOL-5-AMINE
C20H13ClF3N5O (431.07606740000006)
ETHYL [3-(4-BROMOPHENYL)-4,6-DIMETHOXY-1H-INDOL-7-YL]-OXO-ACETATE
(S)-1-(tert-Butoxycarbonyl)-2-(4-iodobenzyl)pyrrolidine-2-carboxylic acid
C17H22INO4 (431.05935220000003)
1-[4-BROMO-2-(HYDROXYMETHYL)PHENYL]-4-(DIMETHYLAMINO)-1-(4-FLUOROPHENYL) BUTAN-1-OL HYDROCHLORIDE
CYCLOPENTADIENYL(FLUORENE)IRON HEXAFLUOROPHOSPHATE
C18H14F6FeP (431.00866560000003)
(3S,5S,6R)-TERT-BUTYL 3-BROMO-2-OXO-5,6-DIPHENYLMORPHOLINE-4-CARBOXYLATE
C21H22BrNO4 (431.07321120000006)
Acetic acid, 2-[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-, ethyl ester
ethyl 5-(benzyloxy)-6-broMo-2-(2-hydroxyethyl)-1-Methyl-1H-indole-3-carboxylate
C21H22BrNO4 (431.07321120000006)
4-Iodo-4,4-dimethoxytriphenylamine
C20H18INO2 (431.03822379999997)
Ferric Maltol
C18H15FeO9 (431.00654299999997)
B - Blood and blood forming organs > B03 - Antianemic preparations > B03A - Iron preparations > B03AB - Iron trivalent, oral preparations D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds
Ioflupane I-123
C18H23FINO2 (431.07574999999997)
V - Various > V09 - Diagnostic radiopharmaceuticals > V09A - Central nervous system > V09AB - Iodine (123i) compounds C1446 - Radiopharmaceutical Compound
[(1s)-1-(5-Chloro-1-Benzothien-3-Yl)-2-(2-Naphthylamino)-2-Oxoethyl]phosphonic Acid
C20H15ClNO4PS (431.0147910000001)
[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]-[4-(1-piperidinylsulfonyl)phenyl]methanone
C20H18ClN3O4S (431.07064980000007)
3-Nitro-4-[[4-(2-oxolanylmethyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]thio]benzamide
N-[4-(2,5-dimethoxyphenyl)-2-thiazolyl]-2-[(4-nitrophenyl)thio]acetamide
2-(2,3-Dihydro-1,4-benzodioxin-6-ylsulfonylamino)benzoic acid thiophen-2-ylmethyl ester
N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-2-(trifluoromethyl)benzamide
(2S,3S,4S,5R)-6-[[3-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5-yl]amino]-3,4,5-trihydroxyoxane-2-carboxylic acid
(2E,5Z)-5-[(3-bromophenyl)methylidene]-2-[(E)-(1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene)hydrazinylidene]-1,3-thiazolidin-4-one
C20H22BrN3OS (431.06668620000005)
benzthiazide
C15H14ClN3O4S3 (430.98349540000004)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
CMP-5-phosphonoformic acid
C10H15N3O12P2 (431.01309699999996)
A cytidine 5-phosphate obtained by formal condensation of the phosphate group of CMP with the phosphono group of phosphonoformic acid.
N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide
C17H10Cl2F3N3O3 (431.00512860000003)
Dedimethylamineoxo-anhydroCl-tetracycline
C20H14ClNO8 (431.04079140000005)
n-[(8r)-1,1,1,15,15-pentachloropentadeca-3,12-diyn-8-yl]ethanimidic acid
(2s)-2-amino-3-(6-bromo-1h-indol-3-yl)-n-[(1e)-2-(3,4,5-trihydroxyphenyl)ethenyl]propanimidic acid
C19H18BrN3O4 (431.04806080000003)
n-(1,1,1,15,15-pentachloropentadeca-3,12-diyn-8-yl)ethanimidic acid
2-amino-3-(6-bromo-1h-indol-3-yl)-n-[2-(3,4,5-trihydroxyphenyl)ethenyl]propanimidic acid
C19H18BrN3O4 (431.04806080000003)